RGLS   $1.48  5.71% Market Closed After Close 1.51 2.03%

Regulus Therapeutics Inc
Total Cash 94.46M
totalCashPerShare 1.443
EBITDA -37.21M
Total Debt 1.42M
quickRatio 17.948
currentRatio 19.065
Total Revenue
debtToEquity 1.448
Revenue/Share
ROA -0.31731
ROE -0.53549
grossProfits
freeCashflow -20.04M
operatingCashflow -32.78M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 4.51M
forwardPE -1.5050505
floatShares 42.38M
sharesOutstanding 65.47M
sharesShort 2.50M
sharesShortPriorMonth 3.29M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.96%
Short Ratio help_outline 7.43%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 1.5
Price To Book help_outline 0.99
earningsQuarterlyGrowth
netIncomeToCommon -35.39M
trailingEps -1.20%
forwardEps -0.99%
enterpriseToEbitda -0.12
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.17 3Q 2024
institutionsCount 88
lastUpdated Nov. 6, 2024, 5:27 p.m.